• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过继性免疫疗法联合放化疗诱导上颌腺样囊性癌分化

Induction of differentiation in maxillary adenoid cystic carcinomas by adoptive immunotherapy in combination with chemoradiotherapy.

作者信息

Ueta E, Osaki T, Yamamoto T, Yoneda K

机构信息

Department of Oral Surgery, Kochi Medical School, Japan.

出版信息

Oral Oncol. 1998 Mar;34(2):105-11. doi: 10.1016/s1368-8375(97)00063-8.

DOI:10.1016/s1368-8375(97)00063-8
PMID:9682772
Abstract

The successful treatment results of a case of maxillary adenoid cystic carcinoma (ACC) and the possibility of differentiation of ACC cells with chemoradioimmunotherapy are described. Combined therapy was applied to two maxillary ACCs. Adoptive immunotherapy consisted of intra-arterial injection of lymphokine-activated killer cells (total 9.0 x 10(8) cells) and recombinant interleukin-2 (1.8 x 10(5) U) and interferon-gamma (1.8 x 10(5) U) was combined with 60Co radiation (50 Gy), 5-fluorouracil (4000 mg) and peplomycin (10 mg). Immunohistochemical staining of the biopsy material obtained during the therapy revealed a marked decrease of proliferating cell nuclear antigen-positive cells and a prominent increase of Lewis Y antigen- and bone morphogenetic protein-2-positive cells. The disappearance of tumour cells and the remodeling of the sinus wall with calcification in the sinus cavity, which had been occupied by the tumour, were observed after therapy in both patients. Adoptive immunotherapy in combination with chemoradiotherapy is useful for the treatment of ACC.

摘要

本文描述了一例上颌腺样囊性癌(ACC)的成功治疗结果以及通过放化疗免疫疗法使ACC细胞分化的可能性。联合疗法应用于两例上颌ACC。过继性免疫疗法包括动脉内注射淋巴因子激活的杀伤细胞(共9.0×10⁸个细胞)、重组白细胞介素-2(1.8×10⁵U)和干扰素-γ(1.8×10⁵U),并联合60Co放疗(50Gy)、5-氟尿嘧啶(4000mg)和培普利霉素(10mg)。治疗期间获取的活检材料的免疫组织化学染色显示增殖细胞核抗原阳性细胞显著减少,而Lewis Y抗原和骨形态发生蛋白-2阳性细胞显著增加。治疗后在两名患者中均观察到肿瘤细胞消失以及鼻窦壁重塑,鼻窦腔内曾被肿瘤占据的部位出现钙化。过继性免疫疗法联合放化疗对ACC治疗有效。

相似文献

1
Induction of differentiation in maxillary adenoid cystic carcinomas by adoptive immunotherapy in combination with chemoradiotherapy.过继性免疫疗法联合放化疗诱导上颌腺样囊性癌分化
Oral Oncol. 1998 Mar;34(2):105-11. doi: 10.1016/s1368-8375(97)00063-8.
2
Induction of bone formation in an adenoid cystic carcinoma of the maxillary sinus by adoptive immunotherapy involving intra-arterial injection of lymphokine-activated killer cells and recombinant interleukin-2 in combination with radiotherapy.
J Biol Response Mod. 1990 Jun;9(3):329-34.
3
[Contribution to the x-ray diagnosis of "cylindromas" of the maxillary region].[对上颌区域“圆柱瘤”的X线诊断的贡献]
Fortschr Geb Rontgenstr Nuklearmed. 1968 Dec;109(6):752-8.
4
Adenoid cystic carcinoma of the paranasal sinuses: retrospective series and review of the literature.鼻腔鼻窦腺样囊性癌:回顾性系列研究和文献复习。
Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Nov;130(5):257-62. doi: 10.1016/j.anorl.2012.09.010. Epub 2013 Jun 6.
5
[Experimental study of adoptive immunotherapy for adenoid cystic carcinoma of the salivary gland].[唾液腺腺样囊性癌过继性免疫治疗的实验研究]
Zhonghua Kou Qiang Yi Xue Za Zhi. 1996 Sep;31(5):271-3.
6
Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery.经颞浅动脉超选择性动脉内灌注化疗联合放疗治疗上颌窦腺样囊性癌
Head Neck. 2013 Mar;35(3):E89-93. doi: 10.1002/hed.21925. Epub 2011 Sep 26.
7
Adenoid cystic carcinoma of the lacrimal gland in a 14-year-old male.一名14岁男性的泪腺腺样囊性癌。
Orbit. 2017 Dec;36(6):448-451. doi: 10.1080/01676830.2017.1337187. Epub 2017 Jul 24.
8
Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer.动脉内注射顺铂并同步放疗后行手术治疗晚期鼻窦癌。
Arch Otolaryngol Head Neck Surg. 2004 Aug;130(8):948-55. doi: 10.1001/archotol.130.8.948.
9
Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.海绵窦受累不是影响鼻窦腺样囊性癌原发肿瘤部位治疗效果的危险因素。
J Otolaryngol Head Neck Surg. 2018 Feb 5;47(1):12. doi: 10.1186/s40463-018-0257-z.
10
Adenoid cystic carcinoma of head and neck: apropos of a case.头颈部腺样囊性癌:附1例报告
BMJ Case Rep. 2012 Aug 21;2012:bcr0220125914. doi: 10.1136/bcr-02-2012-5914.

引用本文的文献

1
Drug resistance mechanism and reversal strategy in lung cancer immunotherapy.肺癌免疫治疗中的耐药机制及逆转策略
Front Pharmacol. 2023 Sep 19;14:1230824. doi: 10.3389/fphar.2023.1230824. eCollection 2023.
2
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.腺样囊性癌:基于基因组分析的当前治疗方法及潜在治疗进展
Oncotarget. 2015 Nov 10;6(35):37117-34. doi: 10.18632/oncotarget.5076.